老年起病与年轻起病类风湿关节炎患者的表型与治疗比较
基于METEOR国际注册数据库7912例RA患者,按起病年龄分为<45岁、45-65岁、>65岁三组,比较基线特征、初始治疗及治疗反应。>65岁组男性更多、血清阴性RA更多且炎症指标略高,初始治疗选择仅略有差异;换药时间及DAS、HAQ改善在各年龄组间无临床相关差异。
要点
- 老年起病RA(>65岁)男性更多、血清阴性更多、炎症指标略高。
- 各年龄组初始治疗选择仅略有差异,首次换药时间相似。
- DAS与HAQ改善随年龄组不同而有统计学交互,但差异无临床意义。
核心结论
- 老年起病RA患者表型与年轻起病者不同,但换药时机及DAS、HAQ治疗反应无临床相关差异。
研究设计与样本
- 使用全球METEOR注册数据库的日常实践数据,纳入7912例RA患者。
- 按诊断时年龄分层为<45岁、45-65岁、>65岁三组。
- 初始治疗组间比较;Cox回归分析年龄组对首次换药时间的影响;线性混合模型在校正潜在混杂后评估DAS与HAQ反应差异。
主要发现
- <45岁与45-65岁组相比>65岁组,DAS每月差异分别为-0.02与-0.05分。
- <45岁与45-65岁组相比>65岁组,HAQ每月差异分别为-0.01与0.02分。
- 上述差异被认为无临床相关性。
临床怎么用
- 老年起病RA的初始治疗与换药决策可参照与年轻患者相似的策略,无需因年龄而显著改变治疗反应预期。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To identify possible differences in baseline characteristics, initial treatment and treatment response between RA patient subgroups based on age at disease onset. METHODS: Daily practice data from the worldwide METEOR registry were used. Patients (7912) were stratified into three age-groups (age at disease diagnosis <45 years, 45-65 years, >65 years). Initial treatment was compared between the different age-groups. With Cox regression analyses the effect of age-group on time-to-switch from first to second treatment was investigated, and with linear mixed models differences in response to treatment (DAS and HAQ) between the age-groups were assessed, after correction for potential confounders. RESULTS: The >65 years age-group included more men, and more seronegative RA with somewhat higher inflammatory markers. Initial treatment choices differed only slightly between the age-groups, and the time-to-switch from initial treatment to the next was similar. DAS and HAQ improvement were dependent on the age-group, reflected by a significant interaction between age-group and outcome. The stratified analysis showed a difference of -0.02 and -0.05 DAS points and, -0.01 and 0.02 HAQ points per month in the <45 and 45-65 years age-groups as compared with the >65 year age group, a difference that did not seem clinically relevant. CONCLUSION: In this international study on worldwide clinical practice, patients with RA onset >65 years include more men and seronegative arthritis, and were initially treated slightly differently than younger patients. We observed no clinically relevant differences in timing of a next treatment step, or response to treatment measured by DAS and HAQ.
引用
- Maassen JM, Bergstra SA, Chopra A, et al. Phenotype and treatment of elderly onset compared with younger onset rheumatoid arthritis patients in international daily practice. Rheumatology (Oxford). 2021. PMID: 33537769. doi:10.1093/rheumatology/keab102
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。